In this study, we explored the underlying mechanism by which intraperitoneally delivered MSCs alleviated colitis and found that MSC-derived THBS1 could boost IL-10-producing B cells through THBS1-mediated TGF-β activation, thereby suppressing colon inflammation and preventing the recurrence of colitis. This evidence concerns the gene TGFB1 and colitis.